Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos in Symptomatic Obstructive Hypertrophic Cardiomyopathy at the European Society of Cardiology Congress 2026 Life Science Investing
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update Psychedelics Investing
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference Life Science Investing
U.S. FDA Approves Gilead's Bixlenvo, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens Life Science Investing
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine Pharmaceutical Investing
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan for Relapsed/Refractory Metastatic Colorectal Cancer Life Science Investing
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial Life Science Investing
